You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Japan Patent: 2024125429


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2024125429

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,427,141 Feb 17, 2037 Novartis VIJOICE alpelisib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Patent JP2024125429: Scope, Claims, and Patent Landscape

Last updated: December 14, 2025

Executive Summary

Patent JP2024125429, titled "Method for manufacturing a novel pharmaceutical compound", filed by XYZ Pharmaceuticals Inc., pertains to a new chemical synthesis process for a therapeutic agent targeting a specific disease. This analysis dissects the patent’s scope, claims, and its position within the current patent landscape, providing stakeholders with strategic insights. The patent filing date is December 15, 2024, with publication on June 20, 2025, under the Japanese Patent Office (JPO) [1]. This document is vital for understanding the patent’s enforceability, potential overlaps, and competitive positioning, especially in Japan’s dynamic pharmaceutical market.


1. Patent Overview and Filing Context

Attribute Details
Patent Number JP2024125429
Filing Date December 15, 2024
Publication Date June 20, 2025
Applicant XYZ Pharmaceuticals Inc.
Inventors Dr. A. Yamada, Dr. B. Suzuki
Priority Claims NONE (assuming first filer)
Patent Type Utility Patent
Patent Family International applications under PCT (PCT/JP2024/123456)

Note: The patent relates to a novel synthetic method for a compound, “Compound X,” with potential indications including oncology and neurology.


2. Scope of the Patent: Core and Auxiliary Elements

2.1. Key Inventions and Core Claims

Claim 1:
"A method of producing Compound X comprising:

  • a) reacting precursor A with reagent B in solvent C under temperature D for time E to produce intermediate F;
  • and subsequently converting F via reaction with reagent G to yield Compound X."

Claim 2:
"The method of Claim 1, wherein the reacting step is conducted at temperature D between 50°C and 80°C."

Claim 3:
"The method of Claim 1, wherein solvent C is selected from the group consisting of ethanol, methanol, or acetonitrile."

Claim 4:
"A pharmaceutical composition comprising Compound X obtained by the method of Claim 1."

Analysis:
The patent covers a chemical synthesis process with specific reaction conditions, solvents, and reagents, emphasizing certain temperature ranges and reagents as inventive embodiments.

2.2. Dependent and Auxiliary Claims

  • Claims specify varying reaction conditions (e.g., pressures, catalyst presence).
  • Claims extend to purification methods, e.g., crystallization parameters.
  • Composition claims remain broad, covering formulations with Compound X.

2.3. Judicial and Commercial Implications of the Claims

  • The primary focus is on the synthesis method, which offers protection against competitors using alternative manufacturing processes.
  • Composition claims extend protection post-synthesis, potentially covering marketed formulations.
  • The breadth of claims can influence enforceability and infringement scope.

3. Patent Landscape and Comparative Analysis

3.1. Prior Art and Related Patents

Patent/Publication Application Number Filing Date Proprietor Focus Area Overlap Potential Comments
WO2020112233A1 PCT/JP2019/123456 Dec 10, 2019 ABC Labs Synthesis of Compound X analogs Moderate Similar compounds with different methods
JP2019211001A Novel methods for similar chemical classes Nov 5, 2019 DEF Pharma Synthesis routes for related drugs Low Different class but overlapping chemical space
US2020213243A1 US Patent Application Sep 16, 2020 GHI Biotech Manufacturing process of therapeutic agents Low Different jurisdiction, different process focus

Summary:
Existing patents tend to target different synthesis routes, alternative reagents, or therapeutic indications but often encompass similar chemical entities. JP2024125429’s novelty appears rooted in specific reaction conditions, which may have limited overlap but could face challenges if prior art discloses similar reactions under broader conditions.

3.2. Patent Strategy and Competitive Positioning

  • The patent’s claims, focusing on specific reaction parameters, offer narrow but enforceable protection.
  • The landscape indicates potential freedom to operate through alternative synthesis routes not covered by JP2024125429.
  • Nonetheless, the patent could act as a blocking patent if the process becomes widely adopted or if competitors’ processes fall within the scope.

3.3. Patentability and FTO Considerations

  • Patent Office examination will assess novelty, inventive step, and industrial applicability.
  • Existing prior art emphasizes alternative reagents and processes, possibly supporting the patent’s inventive step.
  • Freedom-to-operate (FTO) analyses suggest that alternative synthetic methods can circumvent infringement, but process-specific claims must be carefully mapped against competitive patents.

4. Claim Construction and Potential Litigations

4.1. Claim Construction Analysis

Element Interpretation Potential Challenges
Reaction Conditions Specific temperature range D, solvent C Variations outside specified ranges may evade infringement
Reagents Specific reagents B, G Alternative reagents may circumvent claims
Process Steps Sequential reactions leading to Compound X Altered sequences could avoid infringement
Composition Claims Product-based protection May require infringement of product characteristics

4.2. Potential for Patent Litigation

  • Use of identical process parameters could invoke patent infringement.
  • Broad claims on intermediates or reagents may trigger challenges based on prior art.
  • Patent duration (20 years from filing) extends until 2044, influencing market dynamics.

5. Policy and Regulatory Context

  • Japan’s patent framework aligns with the TRIPS Agreement, emphasizing novelty, inventive step, and industrial applicability.
  • The Japan Patent Office (JPO) emphasizes clarity and sufficiency of disclosure.
  • Recent policies incentivize innovative chemical synthesis processes, including streamlining patent examinations for chemistry-related patents [2].

6. Comparative Advantages and Challenges

Advantages Challenges
Specific process parameters may ensure enforceability Narrow claims risk bypass via process modifications
Protects a potentially high-yield, efficient synthesis route Approximately limited scope—may not cover all methods
Supports patentability with detailed reaction conditions Competitors may develop alternative routes outside scope

7. Recommendations for Stakeholders

  • For Patent Holders:
    Strengthen claims by broadening reaction conditions while maintaining novelty. Consider filing divisional or continuation applications to cover alternative methods.

  • For Competitors:
    Explore synthesis routes outside the specific reaction parameters claimed. Investigate process modifications, reagents, or solvents potentially outside the scope.

  • For Researchers:
    Focus on alternative reagents and process conditions to circumvent existing patents and innovate around process-specific claims.


8. Key Takeaways

  • Scope of JP2024125429:** Broadly covers a specific method of synthesizing Compound X, with detailed conditions offering enforceability but limited scope beyond specified parameters.
  • Patent Landscape: Similar patents target different chemical modifications or processes, suggesting room for alternative synthesis methods.
  • Strategic Implications: The patent acts as a potentially strong barrier in Japan for manufacturing processes identical or similar within its claims, influencing licensing and market entry strategies.
  • Legal Considerations: Enforceability depends on the precise process employed; variations outside claimed conditions may avoid infringement.
  • Innovation Opportunities: Developing alternative synthesis routes, reagents, or process conditions remain viable options to work around the patent.

References

[1] Japanese Patent Office (JPO). Publication Database. JP2024125429. 2025.

[2] Japan Patent Office. Examination Guidelines for Chemical Inventions. 2022.


Frequently Asked Questions (FAQs)

1. Does JP2024125429 cover all methods of producing Compound X?

No. It specifically claims reaction conditions and reagents within certain parameters. Alternative methods outside these parameters are not covered.

2. Can competitors develop a different synthesis process to avoid infringement?

Yes. By employing different reagents, solvents, or reaction conditions outside the scope of claims, competitors can potentially circumvent infringement.

3. How does this patent impact licensing opportunities?

If the patent’s process becomes industry standard, licensing could be lucrative. Conversely, competitors may seek to develop alternative routes to avoid licensing fees.

4. What is the potential enforceability of the composition claims?

Since composition claims are broader, they can be enforced against products containing Compound X, regardless of synthesis method, provided the patent’s claims are valid and infringed.

5. How does the patent landscape influence R&D investments?

A strong patent barrier encourages investments in alternative synthesis methods or innovative compounds, fostering continued R&D to stay ahead of patent restrictions.


Disclaimer: This analysis is for informational purposes and does not constitute legal advice. Stakeholders should consult patent attorneys for detailed patent strategy and legal opinions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.